These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7876567)

  • 1. Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA.
    Caponi L; Pegoraro S; Di Bartolo V; Rovero P; Revoltella R; Bombardieri S
    J Immunol Methods; 1995 Feb; 179(2):193-202. PubMed ID: 7876567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.
    Lin JL; Dubljevic V; Fritzler MJ; Toh BH
    Clin Exp Immunol; 2005 Jul; 141(1):155-64. PubMed ID: 15958082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins.
    Fabien N; Moreira A; Lavergne JP; Desbos A; Surgey P; Alves de Olivera C; Gonzalo P; Venot A; Bienvenu J; Perrier H; Reboud JP; Monier JC
    J Autoimmun; 1999 Aug; 13(1):103-10. PubMed ID: 10441174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
    Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins.
    Mahler M; Kessenbrock K; Raats J; Williams R; Fritzler MJ; Blüthner M
    J Mol Med (Berl); 2003 Mar; 81(3):194-204. PubMed ID: 12682728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic tests for antiribosomal p protein antibodies: a comparative evaluation of immunoblotting and ELISA assays.
    Ghirardello A; Caponi L; Franceschini F; Zampieri S; Quinzanini M; Bendo R; Bombardieri S; Gambari PF; Doria A
    J Autoimmun; 2002; 19(1-2):71-7. PubMed ID: 12367561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus.
    Li J; Shen Y; He J; Jia R; Wang X; Chen X; Wang D; Han L; Zhu L; Chi X; Saschenbrecker S; Dähnrich C; Stöcker W; Schlumberger W; Li ZG
    J Clin Lab Anal; 2013 Mar; 27(2):87-95. PubMed ID: 23400861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system function in systemic lupus erythematosus.
    Elkon K; Weissbach H; Brot N
    Neurochem Res; 1990 Apr; 15(4):401-6. PubMed ID: 1697040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiribosomal antibodies in SLE, infection, and following deliberate immunization.
    Elkon KB; Bonfa E; Weissbach H; Brot N
    Adv Exp Med Biol; 1994; 347():81-92. PubMed ID: 7976736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region.
    Bruner BF; Wynn DM; Reichlin M; Harley JB; James JA
    Ann N Y Acad Sci; 2005 Jun; 1051():390-403. PubMed ID: 16126981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection.
    Kessenbrock K; Fritzler MJ; Groves M; Eissfeller P; von Mühlen CA; Höpfl P; Mahler M
    J Mol Med (Berl); 2007 Sep; 85(9):953-9. PubMed ID: 17668158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients.
    Gerli R; Caponi L; Tincani A; Scorza R; Sabbadini MG; Danieli MG; De Angelis V; Cesarotti M; Piccirilli M; Quartesan R; Moretti P; Cantoni C; Franceschini F; Cavazzana I; Origgi L; Vanoli M; Bozzolo E; Ferrario L; Padovani A; Gambini O; Vanzulli L; Croce D; Bombardieri S
    Rheumatology (Oxford); 2002 Dec; 41(12):1357-66. PubMed ID: 12468814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus.
    Sabbatini A; Dolcher MP; Marchini B; Bombardieri S; Migliorini P
    J Rheumatol; 1993 Oct; 20(10):1679-83. PubMed ID: 7507527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus.
    Barkhudarova F; Dähnrich C; Rosemann A; Schneider U; Stöcker W; Burmester GR; Egerer K; Schlumberger W; Hiepe F; Biesen R
    Arthritis Res Ther; 2011 Feb; 13(1):R20. PubMed ID: 21310064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-P autoantibody production requires P1/P2 as immunogens but is not driven by exogenous self-antigen in MRL mice.
    Hines JJ; Weissbach H; Brot N; Elkon K
    J Immunol; 1991 May; 146(10):3386-95. PubMed ID: 2026870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
    Agmon-Levin N; Gilburd B; Kivity S; Katz BS; Flitman-Katzevman I; Shoenfeld N; Paran D; Langevitz P; Shoenfeld Y
    Isr Med Assoc J; 2009 Jul; 11(7):403-6. PubMed ID: 19911490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of lupus anti-ribosome P antibodies using a recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients' mononuclear cells.
    Magsaam J; Gharavi AE; Parnassa AP; Weissbach H; Brot N; Elkon KB
    Clin Exp Immunol; 1989 May; 76(2):165-71. PubMed ID: 2758693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides.
    Heinlen LD; Ritterhouse LL; McClain MT; Keith MP; Neas BR; Harley JB; James JA
    J Mol Med (Berl); 2010 Jul; 88(7):719-27. PubMed ID: 20396862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic benefit of antibodies against ribosomal proteins in systemic lupus erythematosus.
    Shi ZR; Han YF; Yin J; Zhang YP; Jiang ZX; Zheng L; Tan GZ; Wang L
    Adv Rheumatol; 2020 Aug; 60(1):45. PubMed ID: 32859277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S; Arinuma Y; Takayama M; Yoshio T
    Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.